Pugh Richard, Harrison Wendy, Harris Susan, Roberts Hywel, Scholey Gareth, Szakmany Tamas
Department of Anaesthetics, Glan Clwyd Hospital Bodelwyddan, Wales.
Public Health Wales, Temple of Peace and Health Cardiff, Wales.
Front Microbiol. 2016 Aug 18;7:1271. doi: 10.3389/fmicb.2016.01271. eCollection 2016.
The reported incidence of ventilator-associated pneumonia (VAP) in Wales is low compared with surveillance data from other European regions. It is unclear whether this reflects success of the Welsh healthcare-associated infection prevention measures or limitations in the application of European VAP surveillance methods. Our primary aim was to investigate episodes of ventilator-associated respiratory tract infection (VARTI), to identify episodes that met established criteria for VAP, and to explore reasons why others did not, according to the Hospitals in Europe Link for Infection Control through Surveillance (HELICS) definitions.
During two 14-day study periods 2012-2014, investigators reviewed all invasively ventilated patients in all 14 Welsh Intensive Care Units (ICUs). Episodes were identified in which the clinical team had commenced antibiotic therapy because of suspected VARTI. Probability of pneumonia was estimated using a modified Clinical Pulmonary Infection Score (mCPIS). Episodes meeting HELICS definitions of VAP were identified, and reasons for other episodes not meeting definitions examined. In the second period, each patient was also assessed with regards to the development of a ventilator-associated event (VAE), according to recent US definitions.
The study included 306 invasively ventilated patients; 282 were admitted to ICU for 48 h or more. 32 (11.3%) patients were commenced on antibiotics for suspected VARTI. Ten of these episodes met HELICS definitions of VAP, an incidence of 4.2 per 1000 intubation days. In 48% VARTI episodes, concurrent chest radiography was not performed, precluding the diagnosis of VAP. Mechanical ventilation (16.0 vs. 8.0 days; p = 0.01) and ICU stay (25.0 vs. 11.0 days; p = 0.01) were significantly longer in patients treated for VARTI compared to those not treated. There was no overlap between episodes of VARTI and of VAE.
HELICS VAP surveillance definitions identified less than one-third of cases in which antibiotics were commenced for suspected ventilator-associated RTI. Lack of chest radiography precluded nearly 50% cases from meeting the surveillance definition of VAP, and as a consequence we are almost certainly underestimating the incidence of VAP in Wales.
与其他欧洲地区的监测数据相比,威尔士报告的呼吸机相关性肺炎(VAP)发病率较低。目前尚不清楚这是反映了威尔士医疗保健相关感染预防措施的成功,还是欧洲VAP监测方法应用方面的局限性。我们的主要目的是根据欧洲医院感染控制监测链接(HELICS)的定义,调查呼吸机相关性呼吸道感染(VARTI)事件,确定符合VAP既定标准的事件,并探究其他事件不符合标准的原因。
在2012 - 2014年的两个为期14天的研究期间,研究人员对威尔士所有14个重症监护病房(ICU)中所有接受有创通气的患者进行了审查。确定了临床团队因疑似VARTI而开始使用抗生素治疗的事件。使用改良的临床肺部感染评分(mCPIS)评估肺炎的可能性。确定符合HELICS VAP定义的事件,并检查其他不符合定义的事件的原因。在第二个时期,还根据美国最近的定义,对每位患者的呼吸机相关事件(VAE)的发生情况进行了评估。
该研究纳入了306例接受有创通气的患者;其中282例在ICU住院48小时或更长时间。32例(11.3%)患者因疑似VARTI而开始使用抗生素。这些事件中有10例符合HELICS的VAP定义,发病率为每1000个插管日4.2例。在48%的VARTI事件中,未同时进行胸部X线检查,从而无法诊断VAP。与未接受治疗的患者相比,接受VARTI治疗的患者机械通气时间(16.0天对8.0天;p = 0.01)和ICU住院时间(25.0天对11.0天;p = 0.01)明显更长。VARTI事件和VAE事件之间没有重叠。
HELICS的VAP监测定义识别出的因疑似呼吸机相关性呼吸道感染而开始使用抗生素的病例不到三分之一。胸部X线检查的缺失使近50%的病例无法符合VAP的监测定义,因此,我们几乎肯定低估了威尔士VAP的发病率。